- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Abnormal Hormonal Secretions in Canada
Total 2291 results
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Puerto Rico, Canada, Denmark, Hungary, Serbia, Germany, Greece, Romania, Estonia, Norway
-
Gilead SciencesCompletedType 2 Diabetes MellitusUnited States, Russian Federation, Israel, South Africa, India, Hungary, Ukraine, Canada, Czech Republic, Mexico, Poland
-
National Cancer Institute (NCI)Active, not recruitingOvarian Endometrioid Adenocarcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Ovarian High Grade Serous Adenocarcinoma | Platinum-Resistant... and other conditionsUnited States, Canada
-
Eli Lilly and CompanyRecruitingType 2 DiabetesTaiwan, United States, China, Mexico, Germany, Poland
-
TakedaCompletedDiabetes Mellitus, Type 2United States, Mexico, Guatemala
-
Hoffmann-La RocheActive, not recruitingSolid Tumors | CNS TumorsUnited States, Spain, Korea, Republic of, Canada, Germany, United Kingdom, China, Italy, Hong Kong, France, Taiwan
-
SanofiCompletedType 2 DiabetesUnited States, Canada, Chile, Czech Republic, Estonia, France, Germany, Hungary, Italy, Latvia, Lithuania, Mexico, Poland, Romania, Russian Federation, Spain, Ukraine, United Kingdom
-
Chromaderm, Inc.CompletedDiabetic Neuropathies | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Insulin-DependentCanada, United States, Croatia, Finland, India, Lithuania, Netherlands, United Kingdom
-
CelgeneCompletedMetastatic Pancreatic CancerUnited States, Canada, Spain, Italy, Australia, Germany, France, Austria, Belgium, Russian Federation, Ukraine
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Puerto Rico
-
TakedaCompletedDiabetes MellitusUnited States, Argentina, Canada, Chile
-
Bristol-Myers SquibbMerck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2United States, Chile, Hong Kong, Argentina, Austria, Brazil, Canada, Mexico, Peru, Puerto Rico, Philippines, Thailand, Russian Federation, Poland, Germany, Taiwan, Switzerland
-
Lexicon PharmaceuticalsSanofiCompletedType 1 Diabetes MellitusIsrael, Italy, Spain, Bulgaria, Hungary, Poland, Slovakia, United Kingdom, Austria, Belgium, France, Germany, Lithuania, Netherlands, Romania, Sweden, Switzerland
-
PfizerTerminatedDiabetes Mellitus, Type 1United States, Canada, Brazil, Mexico, Argentina
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2 | Chronic Kidney DiseaseSpain, United States, Italy, Denmark, Poland, South Africa, Canada, France
-
Eli Lilly and CompanyARMO BioSciencesCompletedPancreatic CancerUnited States, Belgium, Spain, Poland, Korea, Republic of, Taiwan, Germany, Italy, France, United Kingdom, Austria, Australia, Canada
-
Eli Lilly and CompanyCompletedDiabetes | Type 2 DiabetesUnited States, China, Germany, Mexico, Brazil, Canada, Japan, Korea, Republic of, Puerto Rico, Czechia, Greece
-
Merck Sharp & Dohme LLCPfizerActive, not recruitingType 2 Diabetes MellitusUnited States, Belgium, Canada, Colombia, Costa Rica, Dominican Republic, France, Guatemala, Hungary, Israel, Italy, Malaysia, Mauritius, Mexico, Philippines, Poland, Russian Federation, Saudi Arabia, Turkey, Ukraine, United Arab... and more
-
SanofiCompletedType 2 Diabetes MellitusUnited States, South Africa, Canada, Czechia, Estonia, Finland, France, Germany, Hungary, Latvia, Mexico, Netherlands, Romania
-
National Cancer Institute (NCI)Celgene CorporationActive, not recruitingGlioma | Hematopoietic and Lymphoid Cell Neoplasm | Lymphoma | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Renal Cell Carcinoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer... and other conditionsUnited States, Canada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Canada, Serbia, Turkey, Russian Federation, India, Latvia, Puerto Rico, Lebanon, Colombia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, India, Puerto Rico, Australia, Spain, Netherlands, Hungary, Brazil, Greece, Romania, Argentina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Italy, Russian Federation, Slovakia, Spain, Ireland, Germany, Turkey, Bulgaria, Hong Kong, Romania, South Africa
-
SanofiCompletedType 2 Diabetes MellitusEstonia, Italy, Israel, United States, Canada, Germany, Romania, Slovakia, Spain
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Israel, Italy, Mexico, United Kingdom, Canada, Denmark, Spain, Netherlands, Malaysia, Taiwan, Germany, Poland, Turkey, Argentina, South Africa, Romania, Thailand, Algeria, Brazil
-
SanofiCompletedObesity | Diabetes Mellitus, Non-Insulin-Dependent | Obesity in DiabetesUnited States, France, Canada, Poland, Germany, Netherlands, Belgium, Czech Republic, Argentina, Finland, United Kingdom
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderUnited States, India, Israel, Italy, United Kingdom, Spain, France, Sweden, Taiwan, Turkey, Germany, South Africa, Puerto Rico
-
BayerCompletedChronic Kidney DiseaseSpain, Belgium, Austria, Germany, Bulgaria, Denmark, Italy, Israel, Sweden, Finland, Slovakia, Ukraine, Poland
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesIsrael, Italy, United Kingdom, Denmark, Spain, Singapore, Taiwan, Germany, France, Hong Kong, Brazil
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Russian Federation, United Kingdom, South Africa
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusSpain, Poland, South Africa, Taiwan, Hong Kong, Norway, Italy, Bulgaria, Latvia, Lithuania, Germany, Turkey, Argentina, Israel, Korea, Republic of, Dominican Republic, Guatemala, Brazil, Colombia, Peru, Philippines, Russian Federation and more
-
Mersana TherapeuticsGOG Foundation; European Network of Gynaecological Oncological Trial Groups...TerminatedUpifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT) (UP-NEXT)Fallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Serous Ovarian CancerUnited States, Australia, Canada
-
Astellas Pharma IncCompletedOvarian Cancer | Solid TumorsUnited States, United Kingdom, Australia, Canada, Switzerland, Czechia, Italy, Poland, Romania, Russian Federation
-
Translational Research in OncologyTerminatedOvarian NeoplasmsUnited States, France, Germany, Israel, Ireland, Spain, Canada, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingProliferative Diabetic RetinopathyChina, India, Japan, Russian Federation, Turkey, Canada, United States, Australia, Korea, Republic of, Brazil, Philippines, Puerto Rico, Taiwan, Argentina, Chile, Mexico
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Peru, Spain, United Kingdom, India, Philippines, Russian Federation, Hong Kong
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, United States, Mexico, Puerto Rico, Philippines, Russian Federation, Ukraine
-
Incyte CorporationTerminatedOvarian Cancer | Genitourinary (GU) TumorsUkraine, United Kingdom, United States, Australia, Canada, Russian Federation
-
Bristol-Myers SquibbCompletedDiabetes, Type 2United States, Canada, Mexico, Puerto Rico, Australia, Poland, Taiwan
-
GlaxoSmithKlineCompletedHypertensionUnited States
-
AmgenActive, not recruitingChemotherapy-induced ThrombocytopeniaUnited States, France, Austria, Hungary, Russian Federation, Romania, Spain, Turkey, Greece, Italy, Bulgaria, Canada, Portugal, Argentina, Poland, Mexico, Colombia, Peru, Brazil, Ukraine
-
Provention Bio, Inc.CompletedType 1 Diabetes MellitusUnited States, Belgium, Canada, Czechia, France, Germany, Hungary, Poland, United Kingdom
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico, Australia, United Kingdom, Mexico, Argentina, Brazil, Israel, Canada
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United Kingdom, United States, Australia, Canada, Poland, Denmark, Spain, Croatia, Sweden, Greece, Belgium, France, New Zealand, South Africa, Israel, Brazil, Ireland, Netherlands, Lithuania, Slovakia
-
BayerRecruitingType 2 Diabetes Mellitus | Chronic Kidney DiseaseUnited States, Germany, Argentina, Belgium, Brazil, Canada, Chile, Colombia, France, Italy, Korea, Republic of, Luxembourg, Mexico, Netherlands, Russian Federation, Saudi Arabia, Singapore, Slovenia, Spain, Switzerland, Taiwan, Th... and more
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, India, Israel, Italy, Japan, Russian Federation, Canada, Austria, Taiwan, Serbia, Germany, Bulgaria, Puerto Rico
-
BiogenTerminatedDiabetes Mellitus | Small Fiber NeuropathyBulgaria, Poland, Spain, United Kingdom, Canada, France, Czechia, Germany, Hungary, Greece, Denmark, Italy, Netherlands, Switzerland
-
OSI PharmaceuticalsCanadian Cancer Trials GroupCompletedPancreatic CancerUnited States, Canada, Australia, Israel, Singapore, United Kingdom, Germany, Belgium, Romania, Poland, Argentina, Brazil, Chile, Greece, Italy, Mexico, New Zealand
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Israel, Italy, Mexico, Poland, Russian Federation, Spain, Canada, Denmark, Taiwan, Malaysia, United Kingdom, Turkey, Germany, Bulgaria, Argentina, Australia, Thailand, Algeria, Brazil
-
ImmunoGen, Inc.Not yet recruitingRecurrent Ovarian Cancer | Folate Receptor-Alpha PositiveUnited States, Spain, Australia, Belgium, Canada, France, Ireland, Italy